SLNO R&D Expenses
Soleno Therapeutics Inc · R&D Expenses
SLNO R&D Expenses
Latest reported$11.27Mperiod ending
SLNO Quarterly R&D Expenses ($702.92K → $11.27M)
Quarterly R&D Expenses
High-resolution chart · PNG
SLNO r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 11,274,000 | |
| 9,558,000 | |
| 8,405,000 | |
| 9,147,000 | |
| 13,517,000 | |
| 21,486,000 | |
| 30,138,000 | |
| 12,342,000 | |
| 14,602,000 | |
| 8,689,000 | |
| 6,043,000 | |
| 5,141,000 | |
| 5,316,000 | |
| 3,810,000 | |
| 3,771,000 | |
| 3,696,000 | |
| 3,988,000 | |
| 3,734,000 | |
| 4,968,000 | |
| 5,587,000 | |
| 7,164,000 | |
| 5,566,000 | |
| 4,827,000 | |
| 6,103,000 | |
| 6,695,000 | |
| 5,272,000 | |
| 4,490,000 | |
| 3,745,000 | |
| 2,760,000 | |
| 2,192,000 | |
| 2,092,000 | |
| 1,714,000 | |
| 1,180,000 | |
| 1,022,742 | |
| 982,000 | |
| 974,000 | |
| 994,000 | |
| 953,803 | |
| 1,131,000 | |
| 1,327,000 | |
| 1,772,000 | |
| 1,284,244 | |
| 1,193,000 | |
| 1,181,000 | |
| 878,000 | |
| 609,216 | |
| 717,000 | |
| 549,000 | |
| 372,054 | |
| 359,832 | |
| 745,000 | |
| 571,935 | |
| 702,920 |